Insulin resistance and cardiovascular disease

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 713-718

  McFarlane, Samy I ^a   Banerji, Maryann ^a   Sowers, James R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C;

ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENDOTHELIUM; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MICROALBUMINURIA; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ANIMALS; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL; OBESITY;

EID: 0035093256     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.2.713     Document Type: Article

References (68)

1. Insulin action and insulin resistance: Diseases involving defects in insulin receptors, signal transduction and glucose transport effector system
2. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis
3. Hypertension and associated metabolic abnormalities: The role of insulin resistance and sympathetic adrenal system
4. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM
5. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology
6. Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism
7. Insulin-like growth factor 1 as a cardiac hormone: Physiological and pathophysiological implications in heart disease
8. Insulin-like growth factors
9. Insulin-stimulated production of nitric oxide is inhibited by Wortmannin: Direct measurement in vascular endothelial cells that are also involved with glucose metabolism
10. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells
11. +-pump stimulation by IGF-I in VSMC
12. Insulin-like growth factor but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a Wortrnannin-sensitive pathway: Studies in rat and ferret isolated muscles
13. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels
14. Cross-talk between insulin and angiotensin signaling systems
15. Insulin, cation metabolism and insulin resistance
16. Insulin increases the association of Akt-2 with Glut 4 containing vesicles
17. Insulin resistance in essential hypertension
18. Resistance to insulin stimulated glucose uptake in patients with hypertension
19. Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats
20. Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in SHR and WKY rats
21. Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats
22. Insulin hypersecretion: A distinctive feature between essential and secondary hypertension
23. Insulin resistance in offspring of hypertensive parents
24. Hyperinsulinemia in normotensive offspring of hypertensive parents
25. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland
26. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations
27. Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease
28. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study, 15-year follow-up
29. Hyperinsulinemia as an independent risk factor for ischemic heart disease
30. Non-insulin dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness index, the ARIC study
31. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk
32. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke
33. Insulin resistance as an independent risk for carotid wall thickening
34. Insulin and blood pressure among healthy children: Cardiovascular risk in young Finns
35. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension
36. Insulin resistance, body fat distribution, and sex hormones in men
37. The dense LDL phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
38. Relationships of visceral adipose tissue and glucose disposal in independent of sex in black NIDDM subjects
39. Hypertension in type II diabetes: Update on therapy
40. Diabetes and cardiovascular disease
41. Patients with alcohol problems
42. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
43. Risk variable clustering in the insulin resistance syndrome. The Framingham offspring study
44. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor 1: Implications for vascular disease in hyperinsulinemic states
45. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promotor by glucose in vascular smooth muscle cells
46. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production
47. Serum uric acid is a strong predictor of stroke in patients with non-insulin dependent diabetes
48. Relation of serum uric acid to mortality and ischemic heart disease
49. Serum uric acid and cardiovascular events in successfully treated hypertensive patients
50. Uric acid and coronary heart disease risk: Evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study
51. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms
52. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease
53. Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure
54. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM
55. Microalbuminuria precedes the development of NIDDM
56. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria
57. Metabolic abnormalities in hypertension
58. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities
59. Clustering of endothelial markers of vascular damage in human salt sensitive hypertension. Influence of dietary sodium load and depletion
60. Insulin resistance of glucose uptake in skeletal muscle can not be ameliorated by enhancing endothelium-dependent blood flow in obesity
61. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity
62. Obesity/insulin resistance is associated with endothelial dysfunction: Implications for the syndrome of insulin resistance
63. l-adrenergic reactivity in dorsal hand veins
64. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomized trial
65. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
66. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study
67. Hypertension in type II diabetes: Update on therapy
68. Antihypertensive therapy and the risk of type 2 diabetes mellitus